Centessa Pharmaceuticals Limited (NASDAQ:CNTA) went up by 3.42% from its latest closing price compared to the recent 1-year high of $26.90. The company’s stock price has collected -10.69% of loss in the last five trading sessions. Press Release reported on 10/05/21 that Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer
Is It Worth Investing in Centessa Pharmaceuticals Limited (NASDAQ :CNTA) Right Now?
Opinions of the stock are interesting as 3 analysts out of 3 who provided ratings for Centessa Pharmaceuticals Limited declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $38.67. CNTA currently public float of 12.53M and currently shorts hold a 6.82% ratio of that float. Today, the average trading volume of CNTA was 155.00K shares.
CNTA’s Market Performance
CNTA stocks went down by -10.69% for the week, with a monthly drop of -35.05% and a quarterly performance of -34.03%. The volatility ratio for the week stands at 8.89% while the volatility levels for the past 30 days are set at 10.50% for Centessa Pharmaceuticals Limited. The simple moving average for the period of the last 20 days is -18.26% for CNTA stocks with a simple moving average of -32.20% for the last 200 days.
CNTA Trading at -27.55% from the 50-Day Moving Average
After a stumble in the market that brought CNTA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -47.17% of loss for the given period.
Volatility was left at 10.50%, however, over the last 30 days, the volatility rate increased by 8.89%, as shares sank -32.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.88% lower at present.
During the last 5 trading sessions, CNTA fell by -10.69%, in comparison to the 20-day moving average, which settled at $17.05. In addition, Centessa Pharmaceuticals Limited saw -34.67% in overturn over a single year, with a tendency to cut further losses.